Related Experiment Video
Updated: Sep 20, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
[Coronary heart disease in Mexico and the clinical epidemiological and preventive relevance]
Rafael Chávez Domínguez1, Jorge A Ramírez Hernández, José Miguel Casanova Garcés
1Departamento de Epidemiología, Instituto Nacional de Cardiología Ignacio Chávez, INCICH, Juan Badiano No. 1, Col. Sección XVI, Tlalpan 14080 México, D.F., México. rchavez@cardiologia.org.mx
Insights
Coronary heart disease, a leading cause of death, requires better preventive and acute care. Improving pre-hospital interventions significantly reduces mortality from conditions like acute myocardial infarction (AMI).
Area of Science:
- Cardiology
- Public Health
- Emergency Medicine
Context:
- Coronary heart disease is the leading cause of mortality, with a concerning annual increase.
- Acute myocardial infarction (AMI) accounts for one in three deaths, yet most patients do not reach hospitals.
- Mexico faces higher AMI mortality rates compared to the USA and Canada.
Purpose:
- To highlight the critical need for enhanced preventive and pre-hospital acute care strategies.
- To underscore the importance of timely interventions in reducing cardiovascular mortality.
- To advocate for community awareness and cultural promotion in cardiovascular health.
Summary:
- Atherosclerosis contributes significantly to mortality, with AMI being a major concern.
- Lack of preventive care and delayed hospital access exacerbate cardiovascular mortality.
- Effective pre-hospital care, including CPR and emergency technician training, is vital for saving lives and myocardium.
Impact:
- Implementing improved pre-hospital care can significantly reduce short- and middle-term cardiovascular mortality.
- Reinforcing pre-hospital care reduces delays in critical interventions for AMI.
- Integrating preventive programs with community awareness and emergency response training is essential.
Abstract:
Coronary heart disease is dominant among heart diseases in the population, a problem to control. Heart diseases have been first place in the general mortality for the last 20 years. The trend show an annual increase without control. Atherosclerosis is responsible for at least for one fourth of all deaths in the country. The combined data of mortality and morbidity, from hospital discharges or the whole country, disclose that one out of three die of acute myocardial infarction (AMI). While only 8% of all deaths registered were admitted to a hospital. Most, 92% were never admitted to any hospital for some reason. The estimated annual incidence of AMI cases is 140,000, on the basis of 3 cases surviving for each case death, accounted by the Death Certification System, which rounds 35,000. Standardized mortality rates of AMI in Mexico are greater than in USA o Canada creating a more concerned worry. The most probable explanation to that situation is lack of preventive care, which should also include the acute care and before reaching the hospital facilities. Running the same chances are hypertension crisis and strokes and diabetic complications. The appropriate care for critical situations might reduce significantly the cardiovascular mortality in the country, in a short and middle term. Prevention is not only for chronic conditions but for acute and critical situations. The programs of preventive care should also include cultural promotion and community awareness. The timely care is life and myocardium saving. The reinforcement of prior to hospital care reduces the delay for AMI adequate intervention. These activities agree quite well with the ongoing programs of CPR, organizing the surviving chain and the training programs for paramedical emergency technicians.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies